Xencor (XNCR) Operating Expenses (2013 - 2026)
Xencor (XNCR) reported Operating Expenses of $82.4 million for Q1 2026, up 8.51% year-over-year from $75.9 million in Q1 2025, and up 0.63% quarter-over-quarter from $81.9 million in Q4 2025.
Xencor (XNCR) Operating Expenses (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 14 years of Operating Expenses data on file, last reported at $82.4 million in Q1 2026.
- Operating Expenses for Q1 2026 came in at $82.4 million, up 8.51% year-over-year; the trailing twelve-month figure through Mar 2026 was $309.5 million (up 5.23% YoY), and the FY2025 annual result was $303.1 million, up 4.91% from the prior year.
- Operating Expenses grew to $82.4 million in Q1 2026 per XNCR's latest filing, from $81.9 million in the prior quarter.
- Over five years, Operating Expenses peaked at $82.4 million in Q1 2026 and troughed at $58.2 million in Q2 2022.
- A 5-year average of $72.3 million and a median of $73.0 million in 2024 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2023 and 2024: Operating Expenses soared 32.69% in 2023, then decreased 17.22% in 2024.
- A 5-year view of Operating Expenses shows it stood at $64.2 million in 2022, then increased by 24.13% to $79.7 million in 2023, then declined by 17.22% to $66.0 million in 2024, then climbed by 24.09% to $81.9 million in 2025, then increased by 0.63% to $82.4 million in 2026.
- Business Quant data shows XNCR's Operating Expenses at $82.4 million in Q1 2026, $81.9 million in Q4 2025, and $68.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -67.40 Mn |
| 10 | Xencor | 953.38 Mn | 878.64 Mn | - | 82.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 82.38 Mn |
| Dec 31, 2025 | 81.87 Mn |
| Sep 30, 2025 | 68.52 Mn |
| Jun 30, 2025 | 76.78 Mn |
| Mar 31, 2025 | 75.92 Mn |
| Dec 31, 2024 | 65.97 Mn |
| Sep 30, 2024 | 72.99 Mn |
| Jun 30, 2024 | 79.28 Mn |
| Mar 31, 2024 | 70.66 Mn |
| Dec 31, 2023 | 79.70 Mn |
| Sep 30, 2023 | 77.43 Mn |
| Jun 30, 2023 | 71.52 Mn |
| Mar 31, 2023 | 78.33 Mn |
| Dec 31, 2022 | 64.20 Mn |
| Sep 30, 2022 | 65.65 Mn |
| Jun 30, 2022 | 58.18 Mn |
| Mar 31, 2022 | 59.03 Mn |
| Dec 31, 2021 | 62.36 Mn |
| Sep 30, 2021 | 60.98 Mn |
| Jun 30, 2021 | 58.36 Mn |